MedPath

Iovate Health Sciences International Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:6

Trial Phases

4 Phases

Phase 1:1
Phase 2:2
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (33.3%)
Phase 3
2 (33.3%)
Not Applicable
1 (16.7%)
Phase 1
1 (16.7%)

Acute Effects of Paraxanthine on Energy and Focus

Phase 1
Completed
Conditions
Cognition
Appetite
Mental Energy
Dietary Supplement
First Posted Date
2024-10-07
Last Posted Date
2024-10-08
Lead Sponsor
Iovate Health Sciences International Inc
Target Recruit Count
25
Registration Number
NCT06628596
Locations
🇺🇸

The Center For Applied Health Sciences, Canfield, Ohio, United States

Effect of Different Dosages of Paraxanthine, the Major Caffeine Metabolite, on Energy and Focus

Not Applicable
Completed
Conditions
Focus
Energy
Caffeine Withdrawal
First Posted Date
2023-11-07
Last Posted Date
2023-11-07
Lead Sponsor
Iovate Health Sciences International Inc
Target Recruit Count
45
Registration Number
NCT06117280
Locations
🇺🇸

Citruslabs, Santa Monica, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.